MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
PAVmed P/CF Ratio 2011-2026 | PAVM
Annual P/CF Ratio PAVmed
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.307 | -0.185 | -3.82 | -4.43 | -3.32 | -2.5 | -3.73 | -17 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.185 | -17 | -4.42 |
P/CF Ratio of other stocks in the Medical devices industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
-0.396 | $ 2.21 | 4.69 % | $ 3.45 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
2 | $ 10.52 | 0.91 % | $ 1.42 B | USA |
 |
Allied Healthcare Products
AHPI
|
-0.98 | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-80.1 | - | - | $ 1.77 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
14.1 | $ 8.4 | 0.24 % | $ 603 M |  Israel |
 |
Acutus Medical
AFIB
|
-0.083 | - | -26.83 % | $ 2.62 M | USA |
 |
CONMED Corporation
CNMD
|
7.72 | $ 37.11 | -0.8 % | $ 1.15 B | USA |
 |
Lianluo Smart Limited
LLIT
|
-62.7 | - | 24.59 % | $ 44.8 M |  China |
 |
Butterfly Network
BFLY
|
-18.4 | $ 4.29 | 9.59 % | $ 908 M | USA |
 |
Alphatec Holdings
ATEC
|
45.7 | $ 13.0 | 3.13 % | $ 1.95 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-3.31 | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
-1.24 | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-4.42 | $ 4.06 | 2.55 % | $ 151 M |  France |
 |
Avinger
AVGR
|
-0.18 | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
-0.0136 | - | -13.19 % | $ 166 K | USA |
 |
Boston Scientific Corporation
BSX
|
24.9 | $ 71.0 | 1.73 % | $ 105 B | USA |
 |
Establishment Labs Holdings
ESTA
|
-45.5 | $ 64.75 | 2.0 % | $ 1.92 B |  Costa-rica |
 |
Conformis
CFMS
|
-0.252 | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-3.77 | $ 0.69 | 6.31 % | $ 37.6 M | USA |
 |
Apollo Endosurgery
APEN
|
-12.9 | - | - | $ 475 M | USA |
 |
Cutera
CUTR
|
-0.337 | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
180 | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
6.49 | - | 14.99 % | $ 929 K | USA |
 |
ClearPoint Neuro
CLPT
|
-52 | $ 11.24 | 1.9 % | $ 304 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-0.0621 | - | 1.15 % | $ 34.5 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
885 | - | - | $ 3.31 B | USA |
 |
IRIDEX Corporation
IRIX
|
-7.13 | $ 1.34 | 0.75 % | $ 21.6 M | USA |
 |
Soliton, Inc.
SOLY
|
-18.5 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-1.02 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-30.7 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-6.81 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-25 | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
5.57 | $ 18.43 | 0.05 % | $ 121 M | USA |
 |
Helius Medical Technologies
HSDT
|
-0.34 | $ 2.21 | 0.68 % | $ 1.34 M | USA |
 |
GBS
GBS
|
-0.256 | - | -0.57 % | $ 7.12 M | USA |
 |
LivaNova PLC
LIVN
|
15 | $ 62.53 | 1.79 % | $ 3.41 B |  Britain |
 |
InMode Ltd.
INMD
|
10.9 | $ 13.61 | 1.34 % | $ 880 M | Israel |
 |
Intersect ENT, Inc.
XENT
|
-20.1 | - | - | $ 955 M | USA |
 |
MiMedx Group
MDXG
|
10.5 | $ 4.37 | -0.91 % | $ 646 M | USA |
 |
Abbott Laboratories
ABT
|
20.5 | $ 111.35 | 1.27 % | $ 194 B | USA |
 |
Delcath Systems
DCTH
|
14.5 | $ 9.81 | - | $ 351 M | USA |
 |
Bio-Rad Laboratories
BIO
|
17.2 | $ 270.36 | 3.49 % | $ 7.63 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-7.05 | $ 2.59 | -0.12 % | $ 152 M | Israel |
 |
Integra LifeSciences Holdings Corporation
IART
|
14.5 | $ 9.15 | 1.55 % | $ 705 M | USA |
 |
AxoGen
AXGN
|
1.84 K | $ 32.76 | -0.24 % | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
18.9 | $ 176.7 | 4.28 % | $ 13.2 B | USA |
 |
Bruker Corporation
BRKR
|
0.000028 | $ 33.91 | 3.51 % | $ 5.05 K | USA |
 |
BioSig Technologies
BSGM
|
-1.53 | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
-17.7 | $ 3.78 | 3.0 % | $ 155 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-90 | $ 17.37 | 1.52 % | $ 407 M | USA |